Actively Recruiting
GRASS (Grass MATA MPL Real-world Assessment Study)
Led by Allergy Therapeutics · Updated on 2026-03-20
1000
Participants Needed
1
Research Sites
133 weeks
Total Duration
On this page
Sponsors
A
Allergy Therapeutics
Lead Sponsor
B
Bencard Allergie GmbH
Collaborating Sponsor
AI-Summary
What this Trial Is About
Objective of this non-interventional study (NIS) is to collect data on the use of Grassmuno® in routine clinical practice.
CONDITIONS
Official Title
GRASS (Grass MATA MPL Real-world Assessment Study)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patients aged 18 years or older
- Diagnosed with IgE-mediated moderate to severe allergic rhinitis and/or rhinoconjunctivitis triggered by grass pollen
- Treated with Grassmuno4 according to the current Summary of Product Characteristics (SmPC)
- Treatment decision made before study enrollment
You will not qualify if you...
- Patients not sufficiently proficient in or unable to understand German to comprehend study documents
- Presence of any contraindications listed in the current Summary of Product Characteristics (SmPC) for Grassmuno4
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dr. Kasche
Hamburg, Germany
Actively Recruiting
Research Team
R
Ralph Mösges, Univ. Prof. Dr. med. Dipl.-Ing
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here